瞬时弹性成像测定的肝硬度动态变化预测慢性乙型肝炎患者的临床结局
本研究纳入108例接受核苷(酸)类似物治疗和67例接受干扰素治疗的慢性乙型肝炎患者,在基线、48周和96周行瞬时弹性成像,并以METAVIR评分肝活检为参考。肝硬度值与基线丙氨酸氨基转移酶水平相关(r=0.33;P<.001),在不同肝纤维化分期之间差异显著(P<.001);肝硬度下降幅度预测肝纤维化改善的AUC为0.68(P=.029),当下降幅度≥4.1 kPa时预测组织学应答的敏感度和特异度分别为88.2%和50.0%。作者认为瞬时弹性成像可用于诊断和监测抗病毒治疗期间的组织学应答,并有助于避免多次肝活检。
要点
- 肝硬度值在不同肝纤维化分期之间差异显著(P<.001),可用于评估纤维化程度。
- 核苷(酸)类似物组肝硬度均值由治疗前8.7±3.1 kPa降至治疗后5.9±1.6 kPa(P<.001)。
- 肝硬度下降幅度≥4.1 kPa预测组织学应答的敏感度88.2%、特异度50.0%。
核心结论
- 瞬时弹性成像似乎是诊断和监测慢性乙型肝炎患者抗病毒治疗期间组织学应答的有效测量工具,并可能有助于避免多次肝活检。
研究设计与样本
- 研究纳入108例接受核苷(酸)类似物治疗和67例接受干扰素治疗的慢性乙型肝炎患者,以METAVIR评分的肝活检为参考标准,在基线、48周和96周行瞬时弹性成像,并在治疗96周前后获取肝组织。
诊断标准与关键数值
- 肝硬度下降幅度预测肝纤维化改善的AUC为0.68(P=.029)。
- 肝硬度下降幅度≥4.1 kPa时,预测组织学应答的敏感度为88.2%、特异度为50.0%。
临床应用与阅片要点
- 作者认为瞬时弹性成像可用于诊断和监测慢性乙型肝炎患者抗病毒治疗期间的组织学应答,并可能有助于避免多次肝活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We aimed to evaluate the validity of transient elastography in monitoring the antiviral outcomes in patients with chronic hepatitis B.
METHODS: This study included 108 patients treated with nucleos(t)ide analogues and 67 patients treated with interferon (IFN). Liver biopsies were evaluated by the METAVIR score. Transient elastography was performed initially at baseline, 48 weeks, and 96 weeks. Liver tissue was obtained before and after 96 weeks of treatment. The area under the receiver operating characteristic curve was used to examine the diagnostic value of transient elastography in predicting and monitoring outcomes of antiviral treatment.
RESULTS: The liver stiffness value correlated well with the baseline alanine aminotransferase level (r = 0.33; P < .001) and was significantly different among various stages of liver fibrosis (P < .001). In the nucleos(t)ide analogue group, the mean pretreatment and posttreatment liver stiffness values ± SD were 8.7 ± 3.1 and 5.9 ± 1.6 kPa, respectively (P < .001), and they were 9.2 ± 3.7 and 7.2 ± 1.9 kPa (P < .001) in the IFN group. Although the liver stiffness values at baseline between the groups were similar (P = .45), they were 5.9 ± 1.6 kPa in the nucleos(t)ide analogue group and 7.2 ± 1.9 kPa in the IFN group after 48 weeks of treatment (P < .001). With the decreased magnitude liver stiffness for predicting the improvement in liver fibrosis, the area under the receiver operating characteristic curve was 0.68 (P = .029). When the decreased magnitude of liver stiffness was 4.1 kPa or higher, the sensitivity and specificity for predicting a histologic response were 88.2% and 50.0%.
CONCLUSIONS: Our findings suggest that transient elastography is an effective measurement tool for diagnosing and monitoring the histologic response in patients with chronic hepatitis B during antiviral treatment and can help avoid multiple liver biopsies.
引用
- Zeng J, Cai S, Liu J, et al. Dynamic Changes in Liver Stiffness Measured by Transient Elastography Predict Clinical Outcomes Among Patients With Chronic Hepatitis B. J Ultrasound Med. 2016. PMID: 27914175. doi:10.7863/ultra.15.12054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。